Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Investigation|September 20, 2008
Coaxing the liver into preventing autoimmune disease in the brainBrad E Hoffman, Roland W HerzogJournal of Genetic Syndromes & Gene Therapy|December 25, 2012
Optimal Immunofluorescent Staining for Human Factor IX and Infiltrating T Cells following Gene Therapy for Hemophilia BGeoffrey L Rogers, Brad E HoffmanCurrent Gene Therapy|April 10, 2009
Hepatic gene transfer as a means of tolerance induction to transgene productsPaul A LoDuca, Brad E Hoffman, Roland W HerzogCellular Immunology|March 27, 2018
Liver induced transgene tolerance with AAV vectorsGeoffrey D Keeler, David M Markusic, Brad E HoffmanHuman Gene Therapy|March 25, 2009
Improved induction of immune tolerance to factor IX by hepatic AAV-8 gene transferMario Cooper, Sushrusha Nayak, Brad E Hoffman, et al.Cellular Immunology|January 20, 2024
Upregulation of CD8+ regulatory T cells following liver-directed AAV gene therapyCristina D Gaddie, Kevin G Senior, Christopher Chan, et al.Human Gene Therapy|June 28, 2007
Muscle as a target for supplementary factor IX gene transferBrad E Hoffman, Eric Dobrzynski, Lixin Wang, et al.Gene Therapy|March 11, 2020
AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivoLing Yin, Geoffrey D Keeler, Yuanhui Zhang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2017
The Balance between CD8+ T Cell-Mediated Clearance of AAV-Encoded Antigen in the Liver and Tolerance Is Dependent on the Vector DoseSandeep R P Kumar, Brad E Hoffman, Cox Terhorst, et al.Molecular Therapy. Methods & Clinical Development|October 15, 2016
Potential for cellular stress response to hepatic factor VIII expression from AAV vectorIrene Zolotukhin, David M Markusic, Brett Palaschak, et al.Pageof 3